Aviva PLC Regeneron Pharmaceuticals, Inc. Transaction History

Aviva PLC

$36.8 Billion
Q3 2024

A detailed history of Aviva PLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Aviva PLC holds 58,918 shares of REGN stock, worth $43.8 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

58,918

Previous 57,370 2.7%

Holding current value

$43.8 Million

Previous $60.3 Million 2.72%

% of portfolio

0.17%

Previous 0.18%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $1.59 Million - $1.86 Million	1,548 Added 2.7%	58,918 $61.9 Million
Q2 2024 Aug 02, 2024	BUY	$883.2 - $1071.19 $8.9 Million - $10.8 Million	10,081 Added 21.32%	57,370 $60.3 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $5.34 Million - $5.88 Million	5,921 Added 14.31%	47,289 $45.5 Million
Q4 2023 Feb 09, 2024	SELL	$775.18 - $881.7 $2.73 Million - $3.11 Million	-3,524 Reduced 7.85%	41,368 $36.3 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $10.5 Million - $12.8 Million	15,207 Added 51.23%	44,892 $36.9 Million
Q2 2023 Aug 10, 2023	BUY	$700.03 - $830.35 $5.26 Million - $6.24 Million	7,517 Added 33.91%	29,685 $21.3 Million
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $10 Million - $12.2 Million	-14,697 Reduced 39.87%	22,168 $18.2 Million
Q4 2022 Feb 09, 2023	SELL	$705.89 - $766.39 $665,654 - $722,705	-943 Reduced 2.49%	36,865 $26.6 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $757,066 - $955,378	-1,319 Reduced 3.37%	37,808 $26 Million
Q2 2022 Aug 04, 2022	BUY	$548.35 - $738.84 $6.8 Million - $9.16 Million	12,402 Added 46.41%	39,127 $23.1 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $2.68 Million - $3.15 Million	-4,505 Reduced 14.43%	26,725 $18.7 Million
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $298,370 - $368,362	549 Added 1.79%	31,230 $19.7 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $889,746 - $1.06 Million	-1,550 Reduced 4.81%	30,681 $18.6 Million
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $47,752 - $56,412	101 Added 0.31%	32,231 $18 Million
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $128,211 - $157,333	287 Added 0.9%	32,130 $15.2 Million
Q4 2020 Feb 10, 2021	BUY	$478.3 - $607.98 $333,375 - $423,762	697 Added 2.24%	31,843 $15.4 Million
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $461,948 - $558,162	-848 Reduced 2.65%	31,146 $17.4 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $6.41 Million - $8.36 Million	12,988 Added 68.34%	31,994 $20 Million
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $156,659 - $230,404	-466 Reduced 2.39%	19,006 $9.28 Million
Q4 2019 Feb 10, 2020	SELL	$274.13 - $376.51 $256,311 - $352,036	-935 Reduced 4.58%	19,472 $7.31 Million
Q3 2019 Nov 12, 2019	SELL	$273.46 - $318.39 $2.65 Million - $3.09 Million	-9,704 Reduced 32.23%	20,407 $5.66 Million
Q2 2019 Jul 30, 2019	SELL	$299.6 - $414.82 $93,175 - $129,009	-311 Reduced 1.02%	30,111 $9.43 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $143,622 - $169,674	386 Added 1.29%	30,422 $12.5 Million
Q4 2018 Feb 12, 2019	SELL	$335.82 - $403.04 $2.81 Million - $3.37 Million	-8,362 Reduced 21.78%	30,036 $11.2 Million
Q3 2018 Nov 13, 2018	SELL	$351.14 - $408.51 $537,595 - $625,428	-1,531 Reduced 3.83%	38,398 $15.5 Million
Q2 2018 Aug 01, 2018	SELL	$284.6 - $344.99 $104,732 - $126,956	-368 Reduced 0.91%	39,929 $13.8 Million
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $1.24 Million - $1.54 Million	-3,923 Reduced 8.87%	40,297 $13.9 Million
Q4 2017 Feb 13, 2018	SELL	$358.63 - $469.95 $2.02 Million - $2.64 Million	-5,626 Reduced 11.29%	44,220 $16.6 Million
Q3 2017 Nov 13, 2017	SELL	$431.38 - $504.0 $38,824 - $45,360	-90 Reduced 0.18%	49,846 $22.3 Million
Q2 2017 Aug 07, 2017	BUY	N/A	49,936	49,936 $24.5 Million

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account